Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 4
2012 3
2013 1
2014 3
2015 3
2016 4
2017 10
2018 10
2019 14
2020 14
2021 25
2022 17
2023 13
2024 8
2025 9
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIs.
Hirakawa T, Yamaguchi K, Shimoji K, Sakamoto S, Horimasu Y, Masuda T, Nakashima T, Iwamoto H, Hamada H, Hattori N. Hirakawa T, et al. Among authors: horimasu y. Int J Clin Oncol. 2026 Jul 6. doi: 10.1007/s10147-026-03106-y. Online ahead of print. Int J Clin Oncol. 2026. PMID: 42410147 No abstract available.
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective Validation.
Hirakawa T, Yamaguchi K, Takao S, Kanaji N, Matsumoto N, Miyazaki K, Okimoto T, Ando C, Higo H, Yanai M, Kurose K, Nagasaki Y, Watanabe M, Oyama K, Toyoda Y, Taguchi Y, Tada S, Shimoji K, Sakamoto S, Horimasu Y, Masuda T, Nakashima T, Iwamoto H, Hamada H, Hattori N. Hirakawa T, et al. Among authors: horimasu y. Respirology. 2026 Jun 4. doi: 10.1002/resp.70267. Online ahead of print. Respirology. 2026. PMID: 42241716
Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study.
Nomura A, Masuda T, Shimoji K, Takao S, Izumi Y, Araki Y, Takayama Y, Masuda K, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Iwamoto H, Senoo T, Shoda H, Ishikawa N, Yamasaki M, Hamada H, Okada M, Hattori N. Nomura A, et al. Among authors: horimasu y. Transl Lung Cancer Res. 2026 Mar 23;15(3):59. doi: 10.21037/tlcr-2025-aw-1281. Epub 2026 Feb 26. Transl Lung Cancer Res. 2026. PMID: 41982699 Free PMC article.
129 results